Enter at least 3 characters
Home > Press release > Chiesi Acquires NHCO Nutrition® SAS and...

Autorizzo al trattamento dei miei dati personali
ai sensi del D.L. 30 giugno 2003 n. 196
Edit email address
Invalid email
Text email send
Authorize the processing of personal data

Chiesi Acquires NHCO Nutrition® SAS and strengthens its OTC portfolio in France.

Date: 03/09/2018

Parma (Italy), September 3 2018 – Chiesi, an international research-focused healthcare Group (Chiesi Group), today announced that it has completed the acquisition of 100% of NHCO Nutrition® SAS (NHCO) shares, a French company specialized in food supplements commercialized in pharmacies, currently active in the French market. NHCO Nutrition® is a high performance company, which has experienced a double-digit growth among the last five years and reached a turnover of €12 million in 2017.

 

At the forefront of research and innovation in the field of nutrition science and specialized in AminoScience®, NHCO Laboratories is nowadays a key player in the food supplement landscape. NHCO scientific team is specialized in the Research and Development of Amino Acids based formulas.

 

Chiesi Group, already present in the OTC area in key markets such as Italy and Spain, enters the French self-care field thanks to this acquisition, which will enable Chiesi to reinforce its activities in France by reaching this attractive segment.

 

«This takeover will allow NHCO to accelerate its development with the support of Chiesi while capitalizing on the robust base built since its creation 10 years ago. » commented Charles Elkrief, Founder and Operations Manager of NHCO.

 

“This acquisition will further strengthen our OTC portfolio which will enable us to propose a high quality food supplement line to French consumers.” commented Ugo Di Francesco, CEO of Chiesi Group.

 

About Chiesi Group

Based in Parma, Italy, Chiesi is an international research-focused Healthcare Group, with over 80 years of experience in the pharmaceutical industry, present in 26 countries. Chiesi researches, develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is headquartered in Parma (Italy), and integrated with 6 other key R&D groups in France, the USA, the UK, Sweden, and Denmark to advance Chiesi's pre-clinical, clinical and registration programmes. Chiesi employs more than 5,300 people.

 

About NHCO Nutrition® SAS

Founded in 2008 by a pharmacist in Nice, France, conceives, develops and commercializes an innovative and efficient line of food supplements, focused on the value added of Amino Acids with a premium positioning indicated for joint comfort, hair care, vitality and slimness and successfully promoted by its own salesforce.

For more information, visit: www.NHCO-nutrition.com